Monday, November 23, 2020

FDA Expands Approval of Influenza Treatment to Post-Exposure Prevention


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment

New Idea Dropping Tonight (& big AI partnership)

We have a brand new idea coming tonight and discuss the AI partnership announcement between Microsoft and C3.AI ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏...